🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hefei Hengxin Life Science and Technology Co., Ltd. (SHE:301501)
China flag China · Delayed Price · Currency is CNY
22.50
-1.00 (-4.26%)
Nov 18, 2026, 3:04 PM CST

SHE:301501 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,8771,8071,5621,3961,054696.15
Other Revenue
38.0138.0132.3829.5133.8922.75
1,9151,8451,5941,4251,088718.9
Revenue Growth
5.24%15.73%11.86%30.95%51.38%69.37%
Cost of Revenue
1,5601,4081,1781,023786.93524.89
Gross Profit
355.14437.07416.22401.63301.34194.01
Selling, General & Admin
135.74132.6100.2993.4670.7151.85
Research & Development
53.0252.8453.3744.2135.9132.15
Other Operating Expenses
8.899.696.936.044.294.23
Operating Expenses
199.72196.22161.48146.94113.0488.65
Operating Income
155.41240.85254.74254.69188.3105.36
Interest Expense
-4.75-7.45-10.03-5.31-4.41-2.62
Interest & Investment Income
6.255.072.353.011.661.03
Currency Exchange Gain (Loss)
1.691.695.913.657.03-2.4
Other Non Operating Income (Expenses)
-45.56-0.78-0.44-0.39-0.33-0.26
EBT Excluding Unusual Items
113.04239.38252.53255.65192.25101.11
Gain (Loss) on Sale of Investments
4.34.64-0-2.14-5.5-11.29
Gain (Loss) on Sale of Assets
-0.10.340.88-0.30.240.05
Asset Writedown
-3.53-3.67-0.51-2.41-1.17-0.01
Other Unusual Items
48.7848.788.047.26.084.08
Pretax Income
162.49289.46260.95258.01191.9193.94
Income Tax Expense
32.856.8634.236.5625.9512.86
Earnings From Continuing Operations
129.69232.6226.75221.46165.9581.08
Minority Interest in Earnings
-0.42-8.76-6.86-7.59-3.19-0.92
Net Income
129.27223.84219.89213.86162.7780.16
Net Income to Common
129.27223.84219.89213.86162.7780.16
Net Income Growth
-46.75%1.80%2.82%31.39%103.04%207.30%
Shares Outstanding (Basic)
145139111111111105
Shares Outstanding (Diluted)
145139111111111105
Shares Change
9.61%25.00%0.16%-0.04%5.81%-
EPS (Basic)
0.891.611.981.931.470.77
EPS (Diluted)
0.891.611.981.931.470.77
EPS Growth
-51.42%-18.56%2.66%31.45%91.90%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-218.74-188.4-78.75-110.862.589.75
Free Cash Flow Per Share
-1.51-1.36-0.71-1.000.020.09
Dividend Per Share
0.3500.3500.345---
Dividend Growth
1.51%1.51%----
Gross Margin
18.54%23.69%26.11%28.18%27.69%26.99%
Operating Margin
8.11%13.05%15.98%17.87%17.30%14.66%
Profit Margin
6.75%12.13%13.79%15.01%14.96%11.15%
Free Cash Flow Margin
-11.42%-10.21%-4.94%-7.78%0.24%1.36%
EBITDA
278.1339.93322.36297.44221.74129.15
EBITDA Margin
14.52%18.43%20.22%20.87%20.38%17.96%
D&A For EBITDA
122.6899.0867.6242.7533.4323.79
EBIT
155.41240.85254.74254.69188.3105.36
EBIT Margin
8.11%13.05%15.98%17.87%17.30%14.66%
Effective Tax Rate
20.18%19.65%13.11%14.17%13.52%13.69%
Revenue as Reported
1,9151,8451,5941,4251,088718.9
Advertising Expenses
-2.342.5520.551.16